The pharmaceutical landscape is witnessing a shift with the arrival of GLP-1 delivery devices. These cutting-edge formulations offer a potential approach to administering glucagon-like peptide-1 drugs for individuals living with hyperglycemia. Instead of daily shots , a convenient patch applied t